Effects of Cervical Cancer Screening with a Combination of Cervical Cytology and HPV Testing

  • KARUBE Akihiro
    Dept. of Obstetrics and Gynecology, Yuri Kumiai General Hospital
  • SAITO Fumiko
    Dept. of Obstetrics and Gynecology, Yuri Kumiai General Hospital
  • NAGAO Daisuke
    Dept. of Obstetrics and Gynecology, Yuri Kumiai General Hospital
  • TAMURA Daisuke
    Dept. of Obstetrics and Gynecology, Yuri Kumiai General Hospital
  • ONO Natsuki
    Dept. of Obstetrics and Gynecology, Yuri Kumiai General Hospital
  • KIMURA Naoko
    Dept. of Obstetrics and Gynecology, Yuri Kumiai General Hospital

Bibliographic Information

Other Title
  • 由利本荘地区におけるHPV併用検診の結果について
  • ユリ ホンジョウ チク ニ オケル HPV ヘイヨウ ケンシン ノ ケッカ ニ ツイテ

Search this article

Abstract

This study was conducted to clarify the benefits of using cervical cytological examinations and human papilloma virus (HPV) testing in our cervical cancer screening program, which was carried out during the period from April 2012 through March 2013 in the Yuri-Honjo district of Akita Prefecture. A total of 772 women underwent this screening. About 11.3% (87/772) of the examinees tested positive for HPV, and of these 87 women, 64 were also positive for HPV DNA in the examinations subsequently conducted in the outpatient clinic. Of the HPV DNA-positive women who showed no sign of abnormalities in cytology, 67.6% had lesions cervical intraepithelial neoplasia (CIN) 1 and above, and five women had l CIN 2/3. Compared with the conventional cytology which detected nine women with CIN 2/3, our screening method with a combination of cytology and HPV testing found 14 women with CIN 2 or 3. To upgrade the cervical cancer screening, we recommend HPV testing should be used in combination with cervical cytology.

Journal

References(8)*help

See more

Details 詳細情報について

Report a problem

Back to top